Embodiments of the present invention generally relate to syringes and needle assemblies. Specific embodiments of the invention more particularly relate to syringe assemblies that include a needle that is retractable after the intended use to substantially prevent inadvertent exposure to the needle and reuse of the syringe and methods for manufacturing needle assemblies.
Hypodermic syringes are widely used in the medical arts for administering medicaments and for drawing body fluid samples. Generally, hypodermic syringes include a fixedly or removably attached metal needle that has a sharpened distal point for penetrating vial stoppers or a patient's skin. Hypodermic syringes and needles have been used for many years with few problems reported, taking into consideration the vast numbers and needles used. More recently, with the recognition of viral diseases that are transmitted by body fluids and greater sensitivity of the need to protect health care workers from inadvertent contact with previously used needles (commonly referred to as “sharps”) as well as the need to reduce misuse of improperly disposed of needles and syringes, syringes and needles that include provisions to prevent reuse have been developed.
Provisions intended to protect health care workers from accidental needle sticks and prevent reuse of needles and syringes include a variety of sharps collector systems that are widely used in health care facilities. Other developments include needle attachments that may be readily broken off by practitioners once the syringe has completed its intended use. A variety of shielding mechanisms have been developed which are intended to shield the needle or sharp after it has been used, thus reducing the risk of an accidental needle stick. While many of these developments have reduced the incidence of inadvertent exposure of healthcare workers to sharps, most of these devices can readily be overcome by an individual determined to obtain and misuse a hypodermic syringe and needle. As a result of this problem, further developments in the art of hypodermic syringes have resulted in syringes with needles that withdraw into the body of the syringe once their intended use is completed. These are often referred to as retracting needle syringes.
Current conventional (i.e., non-retracting needle) syringes are considered by users to be virtually fault-free and reliable. They are used for a variety of different procedures involving both “one-shot” fill and inject procedures, as well as more complex mixing measuring and delivery functions. For retractable syringes to replace these functional, utilitarian and reliable conventional syringes, retractable syringes should not significantly interfere with the users current practices and they should be substantially reliable. In addition, in view of the fact that current conventional syringes are often manufactured at rates of several hundred per minute and their cost is generally not a significant factor in their usage, retractable syringes must be cost-effective to manufacture.
Most of the available retracting needle devices are somewhat complex, and many require manufacture and assembly of parts with potentially difficult assembly or tight tolerance requirements. Many of the designs depend upon a careful application of forces by the practitioner to draw and expel fluids from the syringe. Also, if the tolerances between the multiple components of the device are not carefully adhered to during manufacture and assembly, normal usage may result in premature activation of the retraction function of the syringe. The problem of premature activation of the retraction function is a problem with many available retracting needle syringes, particularly those that rely upon application of compressive force on the syringe stopper to activate the retraction mechanism. Many of the available retracting needle syringes have substantial undeliverable “dead volumes” that confound the practitioners need for accurate delivery of medicaments from the syringe or that may waste a substantial percentage of a high cost medicament that is left in the dead volume space. The problem of dead volumes may be associated with a syringe that relies on displacement of the plunger rod with respect to the syringe barrel. Previous syringe designs rely on either force against the stopper or displacement of the plunger rod to cause activation of the retraction mechanism.
Accordingly, a need exists for a selectively retractable syringe that can withstand normal forces during injection and avoid premature activation of the retraction mechanism. Moreover, there is a need to reduce the volume of waste space in the syringe and prevent leakage of medication from the syringe.
Embodiments of the invention pertain to a retractable syringe. In one embodiment, syringe including a retractable needle comprises a barrel having a fluid chamber defining a longitudinal axis and including a proximal end, and a distal end adapted to be attached to a needle; a plunger rod having a distal end and proximal end, the plunger rod including an inner sleeve slidably engageable within an outer housing. According to this embodiment, the inner and outer housing are axially moveable with respect to each other upon activation of a decoupling element associated with the plunger rod. The syringe of this embodiment further comprises compressible stopper mounted on the distal end of the of the plunger rod, the stopper being configured such that when distal force is applied to the plunger rod, the stopper is compressed in the direction of the longitudinal axis in an amount to allow distal movement of the plunger rod along the longitudinal axis a distance sufficient to permit activation of the decoupling element, causing the inner sleeve to move distally with respect to the outer housing and retraction of the needle within the syringe barrel.
In another embodiment, a syringe is provided which comprises a barrel having a fluid chamber, an inside surface, a proximal end, a proximal shoulder located on the inside surface, a distal end adapted to be attached to a needle and a ceiling located on the inside surface and adjacent the distal end. According to this embodiment, the syringe further comprises a plunger rod having a distal end and a proximal end, the plunger rod adapted to slidingly engage the inside surface of the fluid chamber, the plunger rod including a hollow outer housing defined by a wall and a hollow inner sleeve slidably receivable within the outer housing and defining a cavity, and a stopper located on the distal end of the plunger rod, the stopper including a distal face and an outer wall surface. The outer housing includes at least one window extending axially through the wall adjacent the proximal end of the plunger rod, and the inner sleeve includes at least one flexible finger adapted to be flexed inwardly towards the cavity, the flexible finger including a distal end, a proximal end, a distal facing ramp surface adapted to engage with the shoulder of the barrel and a distal facing edge. The inner sleeve further includes a proximal facing stop edge, the finger being sized and shaped to be received within the window, the stopper including a distal rib, a proximal rib and a gap region between the ribs located along the outer wall surface, wherein the configuration of the ramp surface and the stopper is such that axial compression of the stopper permits sufficient axial movement of the plunger rod so that ramp surface engages the shoulder of the barrel, causing inward deflection of the fingers and relative movement of the inner sleeve and outer housing and retraction of the needle.
In a further embodiment, a syringe including a retractable needle is provided, the syringe comprising a barrel including a distal end, a proximal end, an inner surface and an engagement surface; a plunger rod having a proximal end a distal end, the plunger rod adapted to be slidably received within the inner surface of the barrel, the plunger rod including an outer member and an inner member sized and configured to be slidably received within the inner member when an activation element is in contact with the engagement surface, the activation element including a flexible member associated with the inner member in contact with the outer member to prevent relative distal movement between the inner and outer members; and a stopper on the distal end of the plunger rod configured to permit axial movement sufficient to allow displacement of the plunger rod to permit the engagement element to contact the activation surface when the stopper is engaged against the distal end of the barrel.
While this invention is satisfied by embodiments in many different forms, there are shown in the drawings and herein described in detail, embodiments of the invention with the understanding that the present disclosure is to be considered as exemplary of the principles of the present invention and is not intended to limit the scope of the invention to the embodiments illustrated. The invention is capable of other embodiments and of being practiced or carried out in various ways.
In this disclosure, a convention is followed wherein the distal end of the device is the end closest to a patient and the proximal end of the device is the end away from the patient and closest to a practitioner.
Referring generally to
Referring particularly to
Referring now to
Referring now to
Inner sleeve 30 is radially sized to slidably fit within hollow outer housing 24 as shown in
In certain embodiments, the plunger 22 further includes alignment features such as one or more bosses 41 located distally on inner sleeve 30 that cooperate with one or more optional alignment channels 43 located distally on the outer housing 24. The alignment channels 43 may fully extend through the wall of the outer housing 24, or, as shown in the Figures, they may form an elongate indentation on the inner surface of the outer housing 24. Referring to
Referring now to
The gap region has an axial length “Lg” that is at least about 30% of the diameter Ds of stopper 46, and in certain embodiments, the axial length “Lg” of the gap region is at least about 40% of the diameter D. Rib 48 includes a distal contact surface 48a, which contacts roof 15 of barrel 14 when the plunger 22 is advanced distally and bottoms out at the distal end of the barrel 14. As best seen in
Further components of the syringe 10, which are common in typical syringes, will now be described. Referring to
Preferably, hub housing 52, hub 60 with needle 12 attached are formed into an assembly. Housing 52 preferably includes male threads (not shown) that cooperate with female threads 55 located at distal end 18 of barrel 14. This allows the releasable attachment of assembly 61 to barrel 14. While threads are preferred, other forms of attachment are known such as press-fit, snap fit and the like and are considered within the scope of the invention.
Seal 17 engages flange 62 of hub 60 thereby forming a substantially fluid tight seal between hub 60 and barrel 14. Thus, leakage is substantially reduced. The seal 17 is preferably made of thermoplastic elastomer, or other elastic material, such as rubber, TPE, silicone or similar property materials. The material is soft enough, Shore A hardness equal to ˜55, to deform at low stresses from user applied torque, with a compression set of less than 25%. The seal may be assembled into the barrel during manufacturing. Alternatively, the seal may be molded to the needle hub.
Barrel 14 may be formed from thermoplastic materials such as polypropylene, polycarbonate, polyethylene and copolymers or any other suitable material used for the manufacture of syringe barrels. Plunger 22 is preferably formed from polypropylene, polyethylene, polystyrene and the like or any other suitable material used for the manufacture of syringe plungers. Cutter 50 is preferably formed form a metallic material such as stainless steel using a deep draw process or any other suitable forming process. Cutter 50 preferably is subjected to secondary processes such as electrochemical treatment, honing, sharpening, grinding and combinations of these processes to produce a sharpened surface at the distal end of cutter 50. The cutter 50 may also be made from plastic materials such as polycarbonate, polyetherketone, glass, ceramics, or mineral-filled polymers.
Referring still to
Referring now to
Referring now to
Referring now to
The fingers 44 of the inner sleeve 30 of the plunger rod 22 are designed so that the plunger 22 is capable of withstanding distal forces of at least about 26 pounds and up to about 55 pounds when the distal edges 45 of fingers 44 engage distal end 40a of windows 40, which prevents the inner sleeve 30 from decoupling from the outer housing 24. This amount of required force prevents premature decoupling of the outer housing 24 and inner sleeve 30. The syringe of the present invention ensures that a full injection dose of medication is delivered before the retracting safety mechanism is activated. The activation of the retraction mechanism is dependent upon the displacement of the plunger rod and application of force to the stopper, rather than the application of force to the stopper alone or displacement of the plunger rod alone. Thus, the inner sleeve 30 will not decouple from the outer housing 24 until the stopper 46 is bottomed out and compressed against the roof 15 of the barrel 14 and compressed a sufficient amount to allow advancement of the plunger rod 22 until activation of the fingers 44 to cause decoupling of the inner sleeve 30 and outer housing 24.
The compression of the stopper 46, particularly the decrease in size of the gap region 53 on the sidewall, dictates the force required to activate the separation of the inner sleeve 30 and outer housing 24 to initiate retraction. As discussed above, when the stopper 46 is bottomed out against roof 15 of the barrel 14, only a portion of the distal face 46a of the stopper is under pressure, namely the distal contact surface 48a in contact with the roof 15. This permits a greater distal displacement of the plunger 22 for the same amount of force that was applied during delivery of the medication. This is because during delivery of the medication, the distal face 46a of the stopper 46 is under resistance from the fluid pressure of the medicament in the syringe barrel 14. After all medicament has been expelled from the syringe and the entire distal face 46a is no longer under pressure, only the distal contact surface 48a in contact with roof 15 is under pressure. Thus, if the user applies the same amount of force as during medicament delivery, the reduced pressure on the stopper 46 will result in a greater distal displacement of the plunger 22. For example, a comparison of the compression of the stopper 46 due to backpressure during delivery of medicament to the compression of the stopper 46 caused by the barrel roof, there is about a two to three-fold increase in compression distance for the same force applied. Thus, if during delivery of medicament the user applies 15 lbs force to the thumbpress 42, the stopper 46 compresses about the same as when the user applies about 5 lbs force when the stopper 46 is bottomed out on the barrel roof 15 due to the reduction in force from the removal of the medication acting across the entire distal surface 46a of the stopper 46.
The hypodermic needles used in accordance with embodiments of the present invention can be formed from conventional materials such as steel. It will be realized by the skilled artisan that medical grade plastics, composites, ceramics, or like materials can be substituted. The needle can be lubricated with various conventional lubricants such as silicone oils to enhance the effects obtained by applicant's geometry. The hypodermic needles can include needles used for administering medicaments, blood and tissue collection, insulin delivery, catheter products utilizing needles.
Syringe 10 of the invention provides practitioners the ability to deliver high viscosity drugs with a lessened chance of premature retraction of the needle. The components of syringe 10 are compatible with the requirements for high speed manufacture because, as described above, many of the components of syringe 10 do not differ substantially in shape or balance from similar components of conventional syringes.
While the foregoing is directed to embodiments of the present invention, other and further embodiments of the invention may be devised without departing from the basic scope thereof, and the scope thereof is determined by the claims that follow.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US2005/028919 | 8/12/2005 | WO | 00 | 6/5/2007 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2006/020953 | 2/23/2006 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
4375815 | Burns | Mar 1983 | A |
4388925 | Burns | Jun 1983 | A |
4449529 | Burns | May 1984 | A |
4527561 | Burns | Jul 1985 | A |
4535769 | Burns | Aug 1985 | A |
4553541 | Burns | Nov 1985 | A |
4616649 | Burns | Oct 1986 | A |
4624253 | Burns | Nov 1986 | A |
4677979 | Burns | Jul 1987 | A |
5431672 | Cote et al. | Jul 1995 | A |
5533970 | Berger et al. | Jul 1996 | A |
5578011 | Shaw | Nov 1996 | A |
5632733 | Shaw | May 1997 | A |
5752968 | Jolly et al. | May 1998 | A |
5792162 | Jolly et al. | Aug 1998 | A |
5797880 | Erskine | Aug 1998 | A |
5830190 | Howell | Nov 1998 | A |
5919201 | Carter et al. | Jul 1999 | A |
5938676 | Cohn et al. | Aug 1999 | A |
5941892 | Cohn et al. | Aug 1999 | A |
6010486 | Carter et al. | Jan 2000 | A |
6036674 | Caizza et al. | Mar 2000 | A |
6053929 | Cohn et al. | Apr 2000 | A |
6086568 | Caizza | Jul 2000 | A |
6090077 | Shaw | Jul 2000 | A |
6177037 | Mayer | Jan 2001 | B1 |
6183440 | Bell | Feb 2001 | B1 |
6221052 | Caizza et al. | Apr 2001 | B1 |
6368303 | Caizza | Apr 2002 | B1 |
6409701 | Cohn | Jun 2002 | B1 |
6413237 | Caizza et al. | Jul 2002 | B1 |
6432087 | Hoeck et al. | Aug 2002 | B1 |
6517516 | Caizza | Feb 2003 | B1 |
6558357 | Hoeck | May 2003 | B1 |
6585690 | Hoeck et al. | Jul 2003 | B1 |
6599268 | Townsend et al. | Jul 2003 | B1 |
6632198 | Caizza | Oct 2003 | B2 |
6689106 | Bush, Jr. et al. | Feb 2004 | B2 |
6776776 | Alchas et al. | Aug 2004 | B2 |
6840291 | Caizza | Jan 2005 | B2 |
6926700 | Bressler et al. | Aug 2005 | B2 |
6932803 | Newby | Aug 2005 | B2 |
6952604 | DeNuzzio et al. | Oct 2005 | B2 |
7018344 | Bressler et al. | Mar 2006 | B2 |
7083599 | Alchas et al. | Aug 2006 | B2 |
7104622 | Fukano et al. | Sep 2006 | B2 |
7108675 | Deboer et al. | Sep 2006 | B2 |
7182734 | Saulenas et al. | Feb 2007 | B2 |
7258678 | Wilkinson et al. | Aug 2007 | B2 |
7294118 | Saulenas et al. | Nov 2007 | B2 |
7344517 | Schiller | Mar 2008 | B2 |
7351224 | Shaw | Apr 2008 | B1 |
7426408 | DeNuzzio et al. | Sep 2008 | B2 |
7597684 | Alchas et al. | Oct 2009 | B2 |
7604613 | Crawford et al. | Oct 2009 | B2 |
7713245 | Cipoletti et al. | May 2010 | B2 |
20030045838 | Woodard et al. | Mar 2003 | A1 |
20030125676 | Swenson et al. | Jul 2003 | A1 |
20030125677 | Swenson et al. | Jul 2003 | A1 |
20030163096 | Swenson et al. | Aug 2003 | A1 |
20030181867 | Bressler et al. | Sep 2003 | A1 |
20040102737 | Wu | May 2004 | A1 |
20050215951 | Saulenas et al. | Sep 2005 | A1 |
20060129173 | Wilkinson | Jun 2006 | A1 |
20070129675 | Summerville et al. | Jun 2007 | A1 |
20070260193 | Chin et al. | Nov 2007 | A1 |
20080097344 | McKinnon et al. | Apr 2008 | A1 |
20080243075 | Shaw | Oct 2008 | A1 |
Number | Date | Country |
---|---|---|
WO9635463 | Nov 1996 | WO |
WO9848869 | Nov 1998 | WO |
WO-03090815 | Nov 2003 | WO |
Number | Date | Country | |
---|---|---|---|
20080097308 A1 | Apr 2008 | US |